AMPH financial statements
The full income statement, balance sheet, and cash-flow statement for Amphastar Pharmaceuticals Inc. (AMPH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 720M-1.7% | 732M+13.6% | 644M+29.1% | 499M+14.0% | 438M+25.1% | |
| 356M-4.8% | 374M+6.5% | 351M+41.1% | 249M+24.6% | 200M+39.3% | ||
| Cost of revenue | 364M+1.6% | 358M+22.1% | 293M+17.3% | 250M+5.1% | 238M+15.3% | |
| 216M+28.0% | 168M+9.3% | 154M+9.0% | 141M+8.9% | 130M-1.9% | ||
| Research & development | 85.8M+16.1% | 73.9M+0.2% | 73.7M-1.4% | 74.8M+22.7% | 60.9M-9.4% | |
| Selling, general & administrative | 85.9M+51.5% | 56.7M+10.1% | 51.5M+14.4% | 45.1M-12.4% | 51.4M+2.1% | |
| General & administrative | 85.9M+51.5% | 56.7M+10.1% | 51.5M+14.4% | 45.1M-12.4% | 51.4M+2.1% | |
| Selling & marketing | 43.9M+16.1% | 37.8M+31.0% | 28.9M+34.0% | 21.5M+23.1% | 17.5M+18.3% | |
| Amortization of intangibles | 25.0M+1.3% | 24.7M+92.7% | 12.8M+1244.9% | 954K-10.9% | 1.07M+3.4% | |
| Operating income | 140M-31.7% | 205M+4.3% | 197M+83.2% | 107M+53.8% | 69.9M+538.0% | |
| Interest expense | 25.5M-16.0% | 30.3M+11.7% | 27.2M+1371.2% | 1.85M+108.6% | 885K+136.6% | |
| Interest & investment income | 8.68M-18.2% | 10.6M+94.4% | 5.46M+313.2% | 1.32M+119.8% | 601K-6.4% | |
| Other non-operating income | 23.0K-99.4% | 4.08M+203.7% | -3.93M-143.3% | 9.07M-37.6% | 14.5M+320.7% | |
| Equity-method income | — | -573K+71.1% | -1.98M-68.3% | -1.18M-465.9% | -208K | |
| Pre-tax income | 124M-34.9% | 190M+10.7% | 171M+47.7% | 116M+37.9% | 84.1M+1714.5% | |
| Income tax | 25.5M-14.0% | 29.7M-6.8% | 31.8M+35.6% | 23.5M+13.8% | 20.6M+482.8% | |
| 98.1M-38.5% | 160M+16.0% | 138M+50.5% | 91.4M+47.1% | 62.1M+4327.4% | ||
| Net income to non-controlling interest | — | — | — | — | 1.19M+487.3% | |
| $2.03-33.7% | $3.06+17.7% | $2.60+49.4% | $1.74+39.2% | $1.25+4066.7% | ||
| EPS (basic) | $2.10-36.2% | $3.29+15.4% | $2.85+51.6% | $1.88+44.6% | $1.30+4233.3% | |
| Weighted-avg shares (basic) | 46.7M-3.5% | 48.4M+0.3% | 48.3M-0.6% | 48.6M+1.6% | 47.8M+1.6% | |
| Weighted-avg shares (diluted) | 48.2M-7.4% | 52.1M-1.8% | 53.0M+1.1% | 52.4M+5.3% | 49.8M+1.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 636M+19.1% | 534M+9.1% | 490M+29.4% | 378M+18.9% | 318M+13.7% | ||
| Cash & equivalents | 170M+12.2% | 152M+5.1% | 144M-7.6% | 156M+23.5% | 126M+36.4% | |
| Short-term investments | 113M+60.8% | 70.0M-37.8% | 113M+472.2% | 19.7M+90.5% | 10.3M-20.5% | |
| Accounts receivable | 144M+5.3% | 136M+18.6% | 115M+29.4% | 88.8M+12.7% | 78.8M+19.4% | |
| Inventory | 177M+15.1% | 154M+45.3% | 106M+2.2% | 104M+11.6% | 92.8M-4.2% | |
| Prepaid expenses | 13.2M-27.8% | 18.2M+101.1% | 9.06M+19.8% | 7.56M+4.0% | 7.27M+7.3% | |
| 1.63B+3.3% | 1.58B+4.3% | 1.51B+103.9% | 742M+10.5% | 672M+6.4% | ||
| Property, plant & equipment | 311M+4.4% | 297M+5.2% | 283M+18.7% | 238M-2.4% | 244M-6.1% | |
| Operating lease right-of-use | 42.9M-8.5% | 46.9M+45.0% | 32.3M+26.5% | 25.6M-5.0% | 26.9M+34.2% | |
| Goodwill | 3.40M+11.6% | 3.05M-5.2% | 3.22M+2.9% | 3.13M-5.6% | 3.31M-15.9% | |
| Intangible assets | 533M-4.5% | 558M-3.9% | 581M+11641.5% | 4.95M-21.9% | 6.33M-15.0% | |
| Long-term investments | — | 11.0M-25.1% | 14.7M | — | — | |
| Deferred tax assets | 42.5M-40.3% | 71.1M+33.6% | 53.3M+38.2% | 38.5M+72.0% | 22.4M-10.3% | |
| Other non-current assets | 31.1M+19.8% | 26.0M+0.3% | 25.9M+24.2% | 20.9M+25.1% | 16.7M+217.4% | |
| 158M-9.0% | 174M-22.9% | 225M+137.6% | 94.9M-8.6% | 104M-7.5% | ||
| Accounts payable | 32.6M+6.8% | 30.5M+20.0% | 25.4M+24.1% | 20.5M-7.7% | 22.2M-8.8% | |
| Accrued liabilities | 116M-8.5% | 127M+86.3% | 67.9M+6.6% | 63.7M-5.3% | 67.3M-5.4% | |
| Short-term & current debt | 1.64M+601.3% | 234K-46.3% | 436K-85.7% | 3.05M+38.3% | 2.20M-82.0% | |
| Current lease liability | 7.93M+16.5% | 6.80M+74.2% | 3.91M+30.1% | 3.00M+0.7% | 2.98M-11.2% | |
| 840M-0.6% | 845M-3.2% | 873M+309.5% | 213M-5.6% | 226M+23.8% | ||
| Long-term debt | 620M+1.0% | 614M+1.7% | 603M+687.0% | 76.6M-2.0% | 78.2M+70.3% | |
| Non-current lease liability | 37.7M-10.0% | 41.9M+40.9% | 29.7M+25.4% | 23.7M-4.1% | 24.7M+41.5% | |
| Operating lease liability (total) | 45.6M-6.3% | 48.7M+44.8% | 33.6M+26.0% | 26.7M-3.6% | 27.7M+33.0% | |
| Finance lease liability | 264K-38.9% | 432K-29.9% | 616K-22.0% | 790K+98.5% | 398K-34.8% | |
| Deferred tax liabilities | — | — | — | 144K-73.0% | 534K-27.9% | |
| Other non-current liabilities | 30.0M+43.1% | 20.9M-7.8% | 22.7M+56.0% | 14.6M-7.0% | 15.7M+18.5% | |
| 789M+7.7% | 732M+14.5% | 639M+21.0% | 529M+18.7% | 446M+10.7% | ||
| Common stock | 6.00K+0.0% | 6.00K+0.0% | 6.00K+0.0% | 6.00K+0.0% | 6.00K+20.0% | |
| Additional paid-in capital | 535M+5.9% | 505M+4.0% | 486M+6.8% | 455M+7.7% | 422M+3.0% | |
| Retained earnings | 667M+17.2% | 569M+39.0% | 409M+50.6% | 272M+50.7% | 180M+53.1% | |
| Treasury stock | 408M+22.7% | 333M+34.5% | 247M+30.6% | 190M+25.9% | 150M+23.5% | |
| Accumulated other comprehensive income | -5.31M+42.1% | -9.18M-8.3% | -8.48M+1.7% | -8.62M-27.5% | -6.76M-81.8% | |
| Total equity incl. non-controlling | 789M+7.7% | 732M+14.5% | 639M+21.0% | 529M+18.7% | 446M-0.7% | |
| Total liabilities & equity | 1.63B+3.3% | 1.58B+4.3% | 1.51B+103.9% | 742M+10.5% | 672M+6.4% | |
| Common shares issued | 61.8M+1.5% | 60.8M+2.5% | 59.4M+2.2% | 58.1M+3.0% | 56.4M+3.1% | |
| Common shares outstanding | 45.6M-4.1% | 47.6M-0.9% | 48.1M-0.1% | 48.1M+0.8% | 47.7M+0.5% | |
| Shares outstanding (cover) | 45.4M-4.8% | 47.7M-0.9% | 48.1M+0.4% | 47.9M-0.5% | 48.1M+1.5% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 156M-26.8% | 213M+16.3% | 184M+105.8% | 89.2M-9.0% | 98.0M+71.1% | ||
| Depreciation & amortization | 56.7M+7.0% | 53.0M+105.8% | 25.7M+104.3% | 12.6M+23.2% | 10.2M+13.2% | |
| Intangible amortization | 25.0M+1.3% | 24.7M+92.7% | 12.8M+1244.9% | 954K-10.9% | 1.07M+3.4% | |
| Share-based compensation | 27.3M+11.9% | 24.4M+20.4% | 20.2M+13.3% | 17.9M-4.4% | 18.7M-8.8% | |
| Deferred income taxes | 28.7M+267.2% | -17.1M-23.7% | -13.9M+12.7% | -15.9M-531.0% | 3.68M+301.7% | |
| Change in receivables | 6.37M-70.6% | 21.7M-16.9% | 26.1M+157.5% | 10.1M-32.1% | 14.9M-26.0% | |
| Change in inventory | 21.1M-56.8% | 48.8M+2730.5% | 1.72M-85.3% | 11.7M+1033.7% | -1.26M+91.8% | |
| -70.3M+43.7% | -125M+80.8% | -649M-1880.4% | -32.8M-14.3% | -28.7M+21.3% | ||
| Capital expenditure | 34.9M-15.0% | 41.0M+7.5% | 38.2M+58.8% | 24.0M-12.5% | 27.5M-18.9% | |
| Free cash flow | 121M-29.7% | 172M+18.6% | 145M+123.1% | 65.1M-7.6% | 70.5M+201.3% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | — | — | — | 421K | — | |
| -67.4M+16.7% | -81.0M-117.8% | 454M+1817.5% | -26.4M+28.6% | -37.0M-1548.2% | ||
| Long-term debt issued | 0.00 | 0.00-100.0% | 845M | 0.00-100.0% | 70.0M+1014.1% | |
| Long-term debt repaid | 223K-97.3% | 8.26M-97.4% | 319M+17792.1% | 1.78M-95.2% | 36.7M+337.3% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 75.6M-11.6% | 85.5M+47.0% | 58.1M+45.7% | 39.9M+38.2% | 28.9M+18.2% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 210K+210.5% | -190K+32.6% | -282K-28.2% | -220K+1.3% | -223K-163.4% | |
| Net change in cash | 18.6M+153.9% | 7.31M+162.0% | -11.8M-139.7% | 29.7M-7.3% | 32.1M+69.2% | |
| Interest paid | 23.2M-13.4% | 26.8M+52.6% | 17.6M+481.3% | 3.02M+43.3% | 2.11M-4.1% | |
| Income taxes paid | 22.7M-43.4% | 40.1M-18.2% | 49.0M+10.3% | 44.4M+448.9% | 8.10M+137.3% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.22B-31.3% | 1.77B-40.3% | 2.96B+118.8% | 1.35B+20.8% | 1.12B+17.6% | |
| P/E | 12.4×+11.7% | 11.1×-49.4% | 21.9×+24.9% | 17.5×-2.9% | 18.1×-97.3% | |
| P/S | 1.7×-30.2% | 2.4×-50.9% | 4.9×+76.4% | 2.8×+9.0% | 2.6×-6.1% | |
| P/B | 1.5×-36.2% | 2.4×-51.5% | 5.0×+85.7% | 2.7×+6.5% | 2.5×+6.2% | |
| P/FCF | 10.0×-2.4% | 10.3×-51.6% | 21.2×+40.5% | 15.1×-5.1% | 15.9×-61.0% | |
| Earnings yield | 8.1%-10.5% | 9.0%+97.5% | 4.6%-19.9% | 5.7%+3.0% | 5.5%+3666.2% | |
| FCF yield | 10.0%+2.4% | 9.7%+106.4% | 4.7%-28.8% | 6.6%+5.4% | 6.3%+156.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AMPH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AMPH filings on SEC EDGAR → Not investment advice.
